Blood Purif. 2018;46(1):3-6. doi: 10.1159/000487917. Epub 2018 Apr 12.
The evidence concerning online hemodiafiltration (HDF) includes the following: (1) the increase of removal of uremic toxin, (2) the prevention of dialysis rerated hypotension, (3) the recovery of survival, and (4) the recovery of dialysis related uncertain symptoms. Although clinical evidence has been noted, the hypothesis of the efficacy of HDF are still indefinite and require further precise research.
有关在线血液透析滤过（HDF）的证据包括以下内容：（1）增加尿毒症毒素的清除率，（2）预防透析再发性低血压，（3）提高生存率，以及（4）恢复与透析相关的不确定症状。尽管已经注意到临床证据，但 HDF 的疗效假说仍不确定，需要进一步进行精确的研究。
